Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M303746200 on May 20, 2003

J. Biol. Chem., Vol. 278, Issue 31, 29145-29152, August 1, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/31/29145    most recent
M303746200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naylor, M. J.
Right arrow Articles by Ormandy, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naylor, M. J.
Right arrow Articles by Ormandy, C. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Neuropeptide Galanin Augments Lobuloalveolar Development*

Matthew J. Naylor {ddagger} §, Erika Ginsburg ¶, Tiina P. Iismaa ||, Barbara K. Vonderhaar ¶, David Wynick ** and Christopher J. Ormandy {ddagger} {ddagger}{ddagger}

From the {ddagger}Development Group, Cancer Research Program and ||Neurobiology Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, New South Wales 2010, Australia, Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892, and **University Research Centre Neuroendocrinology, Bristol University, Marlborough Street, Bristol BS2 8HW, United Kingdom

Mammary lobuloalveolar development during pregnancy is controlled by ovarian sex steroids and pituitary prolactin release. In organ culture these hormones are incapable of reproducing the density and size of lobuloalveoli seen in mice, suggesting the existence of other undiscovered factors. We showed previously that galanin knockout mice fail to lactate sufficiently for pup survival following their first pregnancy. Here we demonstrate that prolactin treatment of galanin knockout mice allows pup survival but does not completely rescue lobuloalveolar development or reduced milk protein expression. When galanin was used in combination with prolactin in mammary organ culture, larger and more numerous lobules were produced than with prolactin alone. Galanin alone produced sustained activation of STAT5a and the induction of milk protein expression but did not induce lobulogenesis. Examination of the transcriptional interaction between galanin and prolactin using oligonucleotide microarrays demonstrated synergistic and antagonistic modes of interaction between these hormones. These data establish a new role for galanin as a hormone augmenting mammary development during pregnancy in concert with prolactin.


Received for publication, April 10, 2003 , and in revised form, May 15, 2003.

* This work was supported in part by Congressionally Directed Medical Research Program Grant DAMD 17-99-1-9185 (to C. J. O.) and by grants from the Cancer Council of New South Wales and the Australian National Health and Medical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a University of New South Wales, Faculty of Medicine, Dean's Research Scholarship.

{ddagger}{ddagger} To whom correspondence should be addressed. Tel.: 612-9295-8329; Fax: 612-9295-8321; E-mail: c.ormandy{at}garvan.org.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCBHome page
M. J. Naylor, N. Li, J. Cheung, E. T. Lowe, E. Lambert, R. Marlow, P. Wang, F. Schatzmann, T. Wintermantel, G. Schuetz, et al.
Ablation of {beta}1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation
J. Cell Biol., November 21, 2005; 171(4): 717 - 728.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Naylor, S. R. Oakes, M. Gardiner-Garden, J. Harris, K. Blazek, T. W. C. Ho, F. C. Li, D. Wynick, A. M. Walker, and C. J. Ormandy
Transcriptional Changes Underlying the Secretory Activation Phase of Mammary Gland Development
Mol. Endocrinol., July 1, 2005; 19(7): 1868 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Genetically Modified Animals in Endocrinology
Endocr. Rev., August 1, 2004; 25(4): 673 - 677.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement